Genicular Artery Embolization (GAE): Evidence, Safety, and Long-Term Outcomes
Genicular Artery Embolization (GAE) is a minimally invasive procedure increasingly used to relieve chronic knee pain caused by osteoarthritis. As interest in GAE grows, so does the body of clinical research evaluating its effectiveness, safety, and appropriate use.
This page reviews what current studies show about GAE, explains who benefits most, outlines known risks and limitations, and clarifies what happens if results are incomplete—so patients can make informed, evidence-based decisions.
For an overview of how the procedure itself works, see our full guide to Genicular Artery Embolization.
Is Genicular Artery Embolization FDA Approved?
Genicular Artery Embolization is performed using FDA-cleared embolic materials that have been safely used for many years in vascular and interventional radiology procedures. While the embolic agents are FDA approved, GAE itself is considered an off-label use of these materials.
Off-label use is common in medicine and means a physician is using an approved device or medication in a way supported by clinical evidence and medical judgment, even if it is not specifically listed on the original FDA labeling. Many widely accepted procedures—including numerous minimally invasive vascular treatments—were initially performed off label.
GAE is performed by trained specialists using image-guided, catheter-based techniques. For patients deciding whether the procedure is appropriate, understanding the clinical evidence supporting GAE is just as important as understanding its regulatory status.
What Does the Clinical Evidence Show?
Pain Relief and Functional Improvement
Peer-reviewed studies published between 2023 and 2025—including randomized controlled trials, multicenter case series, and meta-analyses—consistently show that GAE provides meaningful pain relief and functional improvement in patients with knee osteoarthritis.
Across pooled studies:
- Patients experienced substantial reductions in knee pain, commonly exceeding the minimum clinically important difference (MCID) used by clinicians to define real improvement.
- Average improvements often exceeded 30 points on validated outcome measures such as the VAS (Visual Analog Scale) and WOMAC index.
- Improvements were seen in pain, stiffness, mobility, and daily activity levels at 6 to 12 months after treatment.
These findings are supported by landmark publications such as Bagla et al. in the Journal of Vascular and Interventional Radiology, institutional research from NYU Langone, and recent large-scale meta-analyses evaluating GAE outcomes.
Patients interested in comparative outcomes may also want to review how GAE performs relative to other options, including GAE vs total knee replacement and GAE vs cortisone injections.
How Long Do GAE Results Last?
Available evidence suggests that GAE results are durable for most patients, with published follow-up extending up to two years.
- Most patients maintain meaningful symptom improvement over time.
- Only a small percentage require additional intervention:
- Repeat GAE in approximately 8% of patients
- Progression to total knee replacement in approximately 5% of patients within two years
For a deeper look at durability and expectations over time, see How long genicular artery embolization results last and success rates of GAE in treating knee pain
Who Is a Good Candidate for GAE?
Clinical evidence shows the best outcomes in patients with:
Mild to moderate knee osteoarthritis (Kellgren-Lawrence grades 1–3)
Persistent knee pain despite physical therapy, injections, or oral medications
Patients who are not ready for, medically unfit for, or prefer to avoid knee replacement surgery
Typically between the ages of 40 and 80
Who Should Not Undergo GAE?
GAE is not appropriate for every patient. Based on current evidence and clinical experience, GAE may not be recommended for individuals with:
- Advanced, bone-on-bone osteoarthritis (Kellgren-Lawrence grade 4)
- Significant joint instability or severe deformity
- Active joint or systemic infection
- Severe peripheral arterial disease affecting knee circulation
- Expectations that GAE will regenerate cartilage or permanently cure arthritis
Understanding candidacy is critical, and patients who are not ideal candidates may benefit from reviewing why some patients are not candidates for GAE.
Safety Profile and Known Risks
How Safe Is GAE?
Across multiple studies, GAE has demonstrated a favorable safety profile:
- Technical success rates of approximately 99.7%
- Most reported adverse events are minor, temporary, and self-limited
- No serious long-term complications have been documented in pooled analyses
For patients concerned about the procedure experience itself, see Is GAE painful? A guide to comfort.
Potential Side Effects
Reported side effects are uncommon and generally mild:
- Temporary skin discoloration near the knee (approximately 11% of cases)
- Mild soreness or discomfort following the procedure
Serious complications are rare when GAE is performed by experienced specialists using appropriate imaging guidance.
What Happens If GAE Doesn’t Work?
Patient responses to GAE vary and generally fall into three categories:
Strong responders with significant, lasting pain relief
Partial responders with improvement but persistent symptoms
Non-responders, often due to advanced disease severity or anatomical factors
If GAE does not provide adequate relief, next steps may include:
Repeat embolization in selected cases
Continued non-surgical management
Surgical evaluation, including knee replacement when appropriate
Importantly, GAE does not prevent future knee replacement surgery. Patients weighing options can review GAE vs total knee replacement for comparative considerations.
Limitations of Current Research
While evidence supporting GAE continues to expand, important limitations remain:
- Many studies are single-arm or observational
- Large-scale randomized trials are still emerging
- Long-term structural effects on cartilage are not yet fully defined
Ongoing research aims to clarify durability beyond several years, refine patient selection, and compare GAE with other minimally invasive therapies.
For patients interested in ongoing developments, see the latest research on GAE.
- Summary: What the Evidence Tells Us
Current clinical evidence supports Genicular Artery Embolization as a promising, minimally invasive treatment for knee osteoarthritis-related pain in carefully selected patients. Studies consistently demonstrate meaningful improvements in pain and function, a strong safety profile, and the potential to reduce medication use and delay surgery.For a complete overview of the procedure, visit Genicular Artery Embolization.
- Medical Review & References
This page is based on peer-reviewed randomized controlled trials, multicenter studies, and systematic reviews published between 2023 and 2025, including:
– Bagla et al., Journal of Vascular and Interventional Radiology
– NYU Langone clinical research
– GAUCHO trial review articles
– Meta-analyses published via ScienceDirect and PubMed Central
Schedule a Consultation at Our Manhattan Vein Treatment Center
If you’re looking for a vein specialist near you or a trusted vein treatment center in Manhattan, NY, Fox Vein Care is here to help. Schedule your vein consultation today and take the first step toward healthier legs.
We Accept Most Insurances
We work with most major insurance providers. Contact us to confirm coverage.